Enclosing the Audited Financial Results for the year ended 31.03.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.1 pts less than Nifty Microcap 250 and 2.0 pts less than its Trading - Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Citichem India Ltd reported audited standalone financial results for FY25 (year ended 31 March 2025). Total revenue from operations rose to ₹3,567.89 lakhs from ₹3,151.16 lakhs in FY24, a growth of roughly 13%. Profit before tax improved to about ₹881.81 lakhs versus ₹728.57 lakhs in the previous year, an increase of around 21%. The company's balance sheet strengthened significantly, with share capital rising to ₹680 lakhs (from ₹500 lakhs) and reserves & surplus jumping to ₹1,331.41 lakhs (from ₹252.04 lakhs). Long-term borrowings declined to ₹61.78 lakhs from ₹108.20 lakhs, keeping the debt-equity ratio very low. The auditors (NGST & Associates) issued an unmodified (clean) opinion on the financial results, and no going-concern or qualification issues were raised.
A clean audit with moderate revenue growth, strong profit growth, and a much stronger balance sheet is broadly positive for shareholders. The company appears financially healthy, though the revenue growth of ~13% falls short of standout territory, so the stock may see only a mildly positive reaction.